☆ 4.6 Letter

Is long-term follow-up without surgical treatment a valid option for hepatic alveolar echinococcosis?

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Long-term follow-up of liver alveolar echinococcosis using echinococcosis multilocularis ultrasound classification

Jasmin Schuhbaur et al.

Summary: The sonomorphology of hepatic AE lesions may change over time, with hemangioma-like and pseudocystic patterns being affected.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Parasitology

Clinical tolerance and efficacy of anti-parasitic treatment with albendazole in patients with alveolar echinococcosis: long-term follow-up observation in 117 patients

Valerij D. Zavoikin et al.

Summary: This study retrospectively analyzed the clinical tolerance and efficacy of albendazole in patients with alveolar echinococcosis, revealing that unresectable patients were more likely to experience adverse reactions. Anti-parasitic treatment demonstrated effectiveness in inhibiting tumor development to some extent.

PARASITOLOGY RESEARCH (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatic Alveolar Echinococcosis

Solange Bresson-Hadni et al.

Summary: Hepatic alveolar echinococcosis (HAE) is a rare zoonotic disease caused by the larval stage of the tapeworm Echinococcus multilocularis. It is predominantly found in China but has seen a significant resurgence in historically endemic areas and emergence in other countries. Diagnosis is typically made through ultrasonography and specific serology, with surgical resection as the main treatment option, though prognosis remains poor in areas with limited access to care.

SEMINARS IN LIVER DISEASE (2021)

添加到收藏夹

Review Microbiology